Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells

Oleg Krut1, Herdis Sommer, Martin Krönke

  • 1Institute for Medical Microbiology, Immunology and Hygiene, Medical Center University of Cologne, Goldenfelsstr. 19-21, 50935 Cologne, Germany.

Abstract

Insights

Certain antibiotics fail to protect host cells from intracellular Staphylococcus aureus (S. aureus) and can promote its persistence. Rifampicin uniquely eradicates intracellular S. aureus, suggesting its value in treating invasive infections.

Area of Science:

  • Microbiology
  • Cell Biology
  • Pharmacology

Background:

  • Some Staphylococcus aureus strains can survive within non-phagocytic host cells, leading to cell death.
  • Understanding the interaction between intracellular S. aureus and host cells is crucial for managing persistent infections.

Purpose of the Study:

  • To investigate the efficacy of various antibiotics against intracellular Staphylococcus aureus.
  • To determine the impact of antibiotics on host cell survival during S. aureus infection.

Main Methods:

  • Murine keratinocyte and fibroblast cell lines were infected with cytotoxic S. aureus.
  • Cells were treated with different antibiotics at various concentrations, and host cell viability was assessed.
  • Bacterial viability within host cells was quantified, and subcellular localization of S. aureus was analyzed using flow cytometry and microscopy.

Main Results:

  • Oxacillin, vancomycin, gentamicin, ciprofloxacin, and trimethoprim/sulfamethoxazole did not prevent host cell death.
  • Linezolid, rifampicin, azithromycin, clindamycin, erythromycin, and quinupristin/dalfopristin inhibited the cytotoxic effects of S. aureus.
  • Only rifampicin eradicated intracellular S. aureus within 72 hours, while others induced persistence.
  • Intracellular S. aureus regained cytotoxic activity upon antibiotic withdrawal.

Conclusions:

  • Commonly used antibiotics may create a niche for intracellular S. aureus, contributing to infection persistence and recurrence.
  • Rifampicin's ability to eliminate intracellular S. aureus makes it a promising therapeutic option for invasive S. aureus infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...